Scholar Rock Holding Corporation (SRRK)
NASDAQ·Healthcare·Biotechnology
$46.55
+0.55%
Mkt Cap $5.44B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $1.83M | — | — | -$0.88 | -$0.88 | +0.29% | — | — |
| Q4 2025 Nov 14, 2025 | $50.00K | — | — | -$0.84 | -$0.90 | -7.76% | — | — |
| Q3 2025 Aug 6, 2025 | $55.56K | — | — | -$0.66 | -$0.98 | -48.48% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.63 | -$0.67 | -6.35% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.60 | -$0.60 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.58 | -$0.66 | -13.77% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.61 | -$0.60 | +1.64% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.51 | -$0.59 | -15.69% | — | — |
| Q1 2024 Mar 19, 2024 | — | $11.66M | — | -$0.49 | -$0.50 | -2.04% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.53 | -$0.53 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.56 | -$0.47 | +16.07% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.57 | -$0.49 | +14.04% | — | — |
| Q1 2023 Mar 7, 2023 | — | $33.19M | — | -$0.58 | -$0.46 | +20.69% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.68 | -$0.55 | +19.12% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$1.03 | -$1.06 | -2.91% | — | — |
| Q2 2022 May 16, 2022 | $22.13M | $33.19M | +49.98% | -$0.79 | -$0.21 | +73.42% | — | — |
| Q1 2022 Mar 7, 2022 | $4.40M | $4.05M | -8.07% | -$1.04 | -$0.97 | +6.73% | — | — |
| Q4 2021 Nov 9, 2021 | $4.64M | $5.46M | +17.76% | -$0.85 | -$1.02 | -20.00% | — | — |
| Q3 2021 Aug 10, 2021 | $4.59M | $4.59M | +0.00% | -$0.78 | -$0.84 | -7.69% | — | — |
| Q2 2021 May 13, 2021 | $5.80M | $4.71M | -18.83% | -$0.69 | -$0.76 | -10.14% | — | — |